[
    [
        {
            "time": "",
            "orginal_text": "那些进医保的药品，卖得咋样？",
            "features": {
                "keywords": [
                    "医保",
                    "药品",
                    "销售"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "那些进医保的药品，卖得咋样？",
            "scores": {
                "News_content": "那些进医保的药品，卖得咋样？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "今日，国产首个肺癌ALK抑制剂“恩沙替尼”开出第一张处方",
            "features": {
                "keywords": [
                    "国产",
                    "肺癌",
                    "ALK抑制剂",
                    "恩沙替尼",
                    "处方"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "今日，国产首个肺癌ALK抑制剂“恩沙替尼”开出第一张处方",
            "scores": {
                "News_content": "今日，国产首个肺癌ALK抑制剂“恩沙替尼”开出第一张处方",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "药品谈判进医保后，销售额达标了吗？",
            "features": {
                "keywords": [
                    "药品谈判",
                    "医保",
                    "销售额"
                ],
                "sentiment_score": 0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药品谈判进医保后，销售额达标了吗？",
            "scores": {
                "News_content": "药品谈判进医保后，销售额达标了吗？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]